Atherosclerosis
Volume 146, Issue 1 , Pages 161-165 , September 1999

Low high density lipoprotein levels are associated with an elevated blood viscosity

Received 13 April 1998 ,Revised 19 February 1999 ,Accepted 23 February 1999.

References 

  1. Crowley JP, Metzger J, Assaf A, Carleton RC, Merrill E, Valeri CR. Low density lipoprotein cholesterol and whole blood viscosity. Ann. Clin. Lab. Sci. 1994;24:533–541
  2. Rosenson RS, McCormick A, Uretz E. Distribution of blood viscosity values and biochemical correlates in healthy adults. Clin. Chem. 1996;42:1189–1195
  3. Koenig W, Sund M, Ernst E, Mraz W, Hombach V, Keli U. Association between rheology and components of lipoproteins in human blood; results from the MONICA project. Circulation. 1992;85:2197–2204
  4. Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin. Sci. 1997;92:473–479
  5. Rosenson RS, Tangney CC. Elevated plasma viscosity contributes to CHD risk in subjects with hypertriglyceridemia. Circulation. 1996;94:1–177Abstract
  6. Rosenson RS, Shott S, Tangney CC. Elevated blood viscosity contributes to coronary heart disease risk in hypertriglyceridemia subjects. Atherosclerosis. 1997;134:94;Abstract
  7. Leonhardt H, Arntz HR, Klemens UH. Studies of plasma viscosity in primary hyperlipoproteinaemia. Atherosclerosis. 1977;28:29–40
  8. Seplowitz AH, Chien S, Smith FR. Effects of lipoproteins on plasma viscosity. Atherosclerosis. 1981;38:89–95
  9. Rosenson RS. Myocardial injury, the acute phase response and lipoprotein metabolism. J. Am. Coll. Cardiol. 1993;22:933–940
  10. Rosenson RS, Staffileno BA, Tangney CC. Effects of tourniquet technique, order of draw and sample storage on plasma fibrinogen. Clin. Chem. 1998;44:688–690
  11. Rosenson RS, Tangney CC. Effects of tourniquet application in plasma viscosity measurements. Clin. Hemorheol. 1998;18:191–194
  12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  13. Clauss A. Quick method to estimate fibrinogen by a functional clotting assay. Acta. Haematol. 1957;17:237–246
  14. Matrai A, Whittington RB, Ernst E. A simple method of estimating whole blood viscosity at standardized hematocrit. Clin. Hemorheol. 1987;7:261–265
  15. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 1990;86:379–384
  16. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Orekhov AN. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem. Biophys. Res. Commun. 1989;163:489–494
  17. Tribble DL, Chu BM, Gong EL, van Venrooij F, Nichols AV. HDL antioxidant effects as assessed using a nonexchangeable probe to monitor particle-specific peroxidative stress in LDL-HDL mixtures. J. Lipid. Res. 1995;36:2580–2589
  18. Miyazaki A, Sakai M, Hakamata H, Horiuchi S. Multi-functional aspects of high density lipoprotein as an anti-atherogenic lipoprotein in vivo: evidence from in vitro experiments using macrophages. J. Atheroscler. Thromb. 1995;2:30–36
  19. Mackness MI, Arrol S, Mackness B, Durrington PN. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet. 1997;349:851–852
  20. Zeiher AM, Schachinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Circulation. 1994;89:2525–2532
  21. Epand RM, Stafford A, Leon B, Lock PE, Tytler EM, Segrest JP, et al. HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Arterioscler. Thromb. 1994;14:1775–1783
  22. Razavian SM, Atger V, Giral Ph, Cambillau M, Del-Pino M, Simon AC, Moatti N, Levenson J, the PCVMETRA Group. Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. Arterioscler Thromb 1994;14:361–366.
  23. Aoyama T, Yui Y, Morishita H, Kawai C. Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris. Circulation. 1990;81:1784–1791
  24. Desai K, Bruckdorfer KR, Hutton RA, Owen JS. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J. Lipid Res. 1989;30:831–840
  25. Ankelkort B, Kiesewetter H. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease. Scand J Clin Lab Invest. 1981;41 Suppl 156:185–188
  26. Koenig W, Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis. 1992;94:93–107
  27. Rosenson RS. Viscosity and ischemic heart disease. J. Vasc. Med. Biol. 1993;4:206–212
  28. Lowe GDO, Lee AJ, Rumley A, Price JF, Fowkes FGR. Blood viscosity and the risk of cardiovascular events: the Edinburgh Artery Study. Br. J. Haematol. 1997;96:168–171
  29. Lee AJ, Mowbray PI, Lowe GDO, Rumley A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women. Circulation. 1998;97:1467–1473

PII: S0021-9150(99)00114-8

Atherosclerosis
Volume 146, Issue 1 , Pages 161-165 , September 1999

Article Tools

* Image Usage & Resolution